Skip to main content

Table 1 Demographic characteristics of total group and according to presence of clinician-determined BCRL

From: The prevalence of lymphoedema in women who attended an information and exercise class to reduce the risk of breast cancer-related upper limb lymphoedema

Characteristic

Total group (N = 40)

Lymphoedema present (N = 12)

No current swelling (N = 28)

Age, years (median, LQ, UQ)

62 (55, 66)

62 (55, 68)

63 (55, 66)

Ethnicity, N (%)

 White British/White Other

35 (88)

9 (75)

26 (93)

 Black and minority ethnic

5 (13)

3 (25)

2 (7)

Employment, N (%)

 Professional/managerial

10 (25)

3 (25)

7 (25)

 Clerical/service/administration

7 (18)

3 (25)

4 (14)

 Skilled trade

2 (5)

1 (8)

1 (4)

 Manual

1 (3)

0

1 (4)

 Homemaker

2 (5)

0

2 (7)

 Retired

16 (40)

5 (42)

11 (39)

 Unemployed

1 (3)

0

1 (4)

 Missing

1 (3)

0

1 (4)

BMI (median, LQ, UQ)

26.05 (23.27, 27.95)

25.57 (24.16, 27.95)

26.50 (21.94, 28.22)

BMI, N (%)

 Normal (18.5–24.9)

15 (38)

4 (33)

11 (39)

 Overweight (25–29.9)

18 (45)

7 (58)

11 (39)

 Obese (≥30)

7 (18)

1 (8)

6 (21)

Time since surgery, months (median, LQ, UQ)

121 (110, 148)

130 (109, 152)

120 (112, 133)

Ipsilateral breast surgery, N (%)

 Wide local excision

19 (46)

6 (50)

14 (50)

 Mastectomy

12 (10)

2 (17)

8 (29)

 Mastectomy + reconstruction

9 (17)

4 (33)

6 (21)

Contralateral surgery, N (%)

 Wide local excision

2 (5)

1 (8)

1 (4)

 Mastectomy

2 (5)

0

2 (7)

Axillary surgery, N (%)

 Sentinel node biopsy/Sampling

4 (10)

0

4 (14)

 Axillary lymph node dissection

36 (90)

12 (100)

24 (86)

Radiotherapy, N (%)

 Breast only

25 (63)

7 (58)

18 (64)

 Breast and supra clavicular fossa

3 (8)

2 (17)

1 (4)

 Breast and axilla

4 (10)

1 (8)

3 (11)

 Breast, SCF and axilla

1 (3)

1 (8)

0

 None

7 (18)

1 (8)

6 (21)

Dominant side treated N (%)

 Yes

14 (37)

6 (50)

8 (29)

 Both sides

5 (12)

1 (8)

4 (14)

 No

21 (51)

5 (42)

16 (57)

Chemotherapy, N (%)

25 (63)

9 (75)

16 (57)

Hormone treatment, N (%)

30 (76)

6 (50)

8 (29)

Cellulitis, N (%)

9 (22)

3 (25)

6 (21)

Patient reported onset of oedema, months after 1st axillary surgery (median, LQ, UQ)

7 (2, 12)

8 (6, 23)

5.5 (1.23, 12)

Patient reported onset of swelling, N (%)

 <3 months

8 (20)

2 (18)

6 (21)

 3–6 months

2 (5)

1 (8)

1 (4)

 >6 months

13 (33)

8 (67)

6 (21)

 Cannot remember

1 (3)

1 (8)

0

 Never developed lymphoedema

15 (38)

0

15 (54)

Reported trigger, N (%)

17 (43)

8 (67)

9 (32)

Received lymphoedema treatment, N (%)

20 (50)

11 (92)

9 (32)

Duration of swelling, months (median, LQ, UQ)*

102.5 (9.9, 129)

118 (96, 134)

54 (10.5, 108)

  1. * No significant differences between groups except for duration of swelling, p = 0.025